Aurinia Pharmaceuticals Inc (0UJF)
LSE
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -51.444 | -57.358 | -38.2 | -52.416 | -25.984 | -35.941 | -21.333 | -15.314 |
Return on Equity (%) | -83.326 | -70.198 | -46.077 | -64.154 | -30.144 | -40.811 | -24.461 | -19.919 |
Return on Invested Capital (%) | -82.224 | -45.846 | -39.574 | -43.581 | -31.644 | -41.974 | -26.449 | -25.422 |
Operating Margin (%) | -13465.318 | -16855.238 | -13833.045 | -38887.736 | -205.064 | -395.145 | -79.349 | -42.558 |
Net Profit Margin (%) | -13465.318 | -16855.238 | -13848.812 | -38945.283 | -204.876 | -396.812 | -80.713 | -44.453 |
Book Value Per Share | 0.386 | 1.804 | 1.169 | 2.346 | 3.144 | 3.324 | 2.805 | 2.593 |
Earnings Per Share | -0.441 | -0.842 | -0.75 | -1.108 | -0.81 | -1.278 | -0.76 | -0.542 |
Cash Per Share | 0.751 | 1.971 | 1.38 | 2.737 | 2.149 | 1.638 | 0.662 | 0.34 |
Working Capital Per Share | 0.634 | 1.988 | 1.469 | 2.718 | 3.057 | 3.338 | 2.787 | 2.417 |
Operating Profit Per Share | 0.003 | 0.005 | 0.005 | 0.003 | 0.395 | 0.314 | 0.913 | 1.126 |
EBIT Per Share | -0.441 | -0.842 | -0.749 | -1.106 | -0.811 | -1.273 | -0.748 | -0.539 |
EBITDA Per Share | -0.441 | -0.842 | -0.749 | -1.106 | -0.811 | -1.273 | -0.748 | -0.539 |
Free Cash Flow Per Share | -0.469 | -0.859 | -0.767 | -1.121 | -0.776 | -1.291 | -0.763 | -0.542 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 52,81M | 84,05M | 85,5M | 111,8M | 126,73M | 141,6M | 142,27M | 143,83M |
Capitalisation boursière | 1,12B |
Ratio cours/bénéfice | -14,66 |
Ratio prix/ventes | 6,51 |
Ratio prix/liquidités | 23,4 |
Ratio prix/valeur comptable | 3,03 |
Rendement de dividende | - |
Actions en circulation | 143,83M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 238 |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 7,80 |
Plus bas sur 52 semaines | 7,80 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales